Strokes are a major cause of death and disability and the third leading cause of death in western society. It is estimated 3% ...

A new study has revealed that mechanically retrieving blood clots from medium- or small-sized brain arteries did not improve ...

Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, ...

A recent study from Chinese researchers reveals that alteplase, a clot-busting medication, can significantly improve recovery outcomes for stroke patients, increasing chances of recovery by over 50% ...

The golden hour for patients with stroke, which occurs when poor blood flow to a part of the brain causes cell death ... The ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors, leading to better ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

A new study suggests that a simple blood test could help emergency responders quickly determine whether a stroke is caused by ...